Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice

BACKGROUND: The primary objective of this study was to estimate the proportion of people living with HIV (PLWH) who switched from a non-protease inhibitor (PI)-based regimen [integrase strand transfer inhibitor (InSTI)-based or non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen] to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranzenigo, Martina, Gianotti, Nicola, Galli, Laura, Poli, Andrea, Mastrangelo, Andrea, Bruzzesi, Elena, Chiurlo, Matteo, Nozza, Silvia, Bossolasco, Simona, Spagnuolo, Vincenzo, Mancusi, Daniela, Termini, Roberta, Carini, Elisabetta, Lazzarin, Adriano, Castagna, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249346/
https://www.ncbi.nlm.nih.gov/pubmed/35783200
http://dx.doi.org/10.2147/DDDT.S358976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249346/
https://www.ncbi.nlm.nih.gov/pubmed/35783200
http://dx.doi.org/10.2147/DDDT.S358976

Ejemplares similares